Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001214659-21-006363
Filing Date
2021-06-07
Accepted
2021-06-07 16:15:23
Documents
1
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-53033.html 3  
1 PRIMARY DOCUMENT marketforms-53033.xml 3 2370
  Complete submission text file 0001214659-21-006363.txt   3820
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Issuer) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address
Ungaro Ursula (Reporting) CIK: 0001865511 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40060 | Film No.: 21999700